Hollsteen
← Meta

Equity incl. NCI

Balance – as of period end · $B

QuartersFiscal years

$BEquity incl. NCI · Q1 2016: $47.1B · 10-Q 0001326801-16-000067 filed Apr 28, 2016Equity incl. NCI · Q2 2016: $50.4B · 10-Q 0001326801-16-000082 filed Jul 28, 2016Equity incl. NCI · Q3 2016: $54.1B · 10-Q 0001326801-16-000087 filed Nov 3, 2016Equity incl. NCI · Q4 2016: $59.2B · 10-K 0001326801-17-000007 filed Feb 3, 2017Equity incl. NCI · Q1 2017: $62.2B · 10-Q 0001326801-17-000024 filed May 4, 2017Equity incl. NCI · Q2 2017: $66.5B · 10-Q 0001326801-17-000038 filed Jul 27, 2017Equity incl. NCI · Q3 2017: $71.2B · 10-Q 0001326801-17-000053 filed Nov 2, 2017Equity incl. NCI · Q4 2017: $74.3B · 10-K 0001326801-18-000009 filed Feb 1, 2018Equity incl. NCI · Q1 2018: $77.6B · 10-Q 0001326801-18-000032 filed Apr 26, 2018Equity incl. NCI · Q2 2018: $79.4B · 10-Q 0001326801-18-000057 filed Jul 26, 2018Equity incl. NCI · Q3 2018: $80.3B · 10-Q 0001326801-18-000067 filed Oct 31, 2018Equity incl. NCI · Q4 2018: $84.1B · 10-K 0001326801-19-000009 filed Jan 31, 2019Equity incl. NCI · Q1 2019: $86.5B · 10-Q 0001326801-19-000037 filed Apr 25, 2019Equity incl. NCI · Q2 2019: $88.8B · 10-Q 0001326801-19-000055 filed Jul 25, 2019Equity incl. NCI · Q3 2019: $94.0B · 10-Q 0001326801-19-000069 filed Oct 31, 2019Equity incl. NCI · Q4 2019: $101.1B · 10-K 0001326801-20-000013 filed Jan 30, 2020Equity incl. NCI · Q1 2020: $105.3B · 10-Q 0001326801-20-000048 filed Apr 30, 2020Equity incl. NCI · Q2 2020: $110.4B · 10-Q 0001326801-20-000076 filed Jul 31, 2020Equity incl. NCI · Q3 2020: $117.7B · 10-Q 0001326801-20-000084 filed Oct 30, 2020Equity incl. NCI · Q4 2020: $128.3B · 10-K 0001326801-21-000014 filed Jan 28, 2021Equity incl. NCI · Q1 2021: $133.7B · 10-Q 0001326801-21-000033 filed Apr 29, 2021Equity incl. NCI · Q2 2021: $138.2B · 10-Q 0001326801-21-000049 filed Jul 29, 2021Equity incl. NCI · Q3 2021: $133.4B · 10-Q 0001326801-21-000065 filed Oct 26, 2021Equity incl. NCI · Q4 2021: $124.9B · 10-K 0001326801-22-000018 filed Feb 3, 2022Equity incl. NCI · Q1 2022: $123.2B · 10-Q 0001326801-22-000057 filed Apr 28, 2022Equity incl. NCI · Q2 2022: $125.8B · 10-Q 0001326801-22-000082 filed Jul 28, 2022Equity incl. NCI · Q3 2022: $124.1B · 10-Q 0001326801-22-000108 filed Oct 27, 2022Equity incl. NCI · Q4 2022: $125.7B · 10-K 0001326801-23-000013 filed Feb 2, 2023Equity incl. NCI · Q1 2023: $124.8B · 10-Q 0001326801-23-000067 filed Apr 27, 2023Equity incl. NCI · Q2 2023: $134.0B · 10-Q 0001326801-23-000093 filed Jul 27, 2023Equity incl. NCI · Q3 2023: $142.9B · 10-Q 0001326801-23-000103 filed Oct 26, 2023Equity incl. NCI · Q4 2023: $153.2B · 10-K 0001326801-24-000012 filed Feb 2, 2024Equity incl. NCI · Q1 2024: $149.5B · 10-Q 0001326801-24-000049 filed Apr 25, 2024Equity incl. NCI · Q2 2024: $156.8B · 10-Q 0001326801-24-000069 filed Aug 1, 2024Equity incl. NCI · Q3 2024: $164.5B · 10-Q 0001326801-24-000081 filed Oct 31, 2024Equity incl. NCI · Q4 2024: $182.6B · 10-K 0001326801-25-000017 filed Jan 30, 2025Equity incl. NCI · Q1 2025: $185.0B · 10-Q 0001326801-25-000054 filed May 1, 2025Equity incl. NCI · Q2 2025: $195.1B · 10-Q 0001628280-25-036791 filed Jul 31, 2025Equity incl. NCI · Q3 2025: $194.1B · 10-Q 0001628280-25-047240 filed Oct 30, 2025Equity incl. NCI · Q4 2025: $217.2B · 10-K 0001628280-26-003942 filed Jan 29, 2026Equity incl. NCI · Q1 2026: $243.7B · 10-Q 0001628280-26-028526 filed Apr 30, 2026Equity incl. NCI · Q2 2026: $261.2B · 10-Q 0001628280-26-050705 filed Jul 30, 2026105.3261.247.1Q1 2016Q2 2026Q1 2020
Q1 2020
105.3$B
All values (42)
PeriodValue ($B)Status
Q2 2026261.2reported
Q1 2026243.7reported
Q4 2025217.2reported
Q3 2025194.1reported
Q2 2025195.1reported
Q1 2025185.0reported
Q4 2024182.6reported
Q3 2024164.5reported
Q2 2024156.8reported
Q1 2024149.5reported
Q4 2023153.2reported
Q3 2023142.9reported
Q2 2023134.0reported
Q1 2023124.8reported
Q4 2022125.7reported
Q3 2022124.1reported
Q2 2022125.8reported
Q1 2022123.2reported
Q4 2021124.9reported
Q3 2021133.4reported
Q2 2021138.2reported
Q1 2021133.7reported
Q4 2020128.3reported
Q3 2020117.7reported
Q2 2020110.4reported
Q1 2020105.3reported
Q4 2019101.1reported
Q3 201994.0reported
Q2 201988.8reported
Q1 201986.5reported
Q4 201884.1reported
Q3 201880.3reported
Q2 201879.4reported
Q1 201877.6reported
Q4 201774.3reported
Q3 201771.2reported
Q2 201766.5reported
Q1 201762.2reported
Q4 201659.2reported
Q3 201654.1reported
Q2 201650.4reported
Q1 201647.1reported

CSV with all sources · Technical ID: equity_total

More metrics for Meta
Sources & calculation
Value
$105.3B
Period
Q1 2020, ended Mar 31, 2020 · as of Mar 31, 2020 (balance as of date, not a sum)
Source
10-Q, filed Apr 30, 2020 · 0001326801-20-000048
Location
us-gaap:StockholdersEquity
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$105.3BApr 30, 202010-Q 0001326801-20-000048reported · confidence 1. · current